Summary of CARDIUM THERAPEUTICS, INC.

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

CXM > SEC Filings for CXM > Form 8-K on 1-Feb-2013

All Recent SEC Filings

Show all filings for CARDIUM THERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for CARDIUM THERAPEUTICS, INC.

1-Feb-2013

Other Events, Financial Statements and Exhibits

ITEM 8.01 OTHER EVENTS.

On January 29, 2013, Cardium Therapeutics, Inc. ("Cardium") issued a press release announcing a presentation, "Optimizing Phase III Trial Design for Generx® (Ad5FGF-4)", at the 2013 Phacilitate Annual Cell & Gene Therapy Forum in Washington, DC, by Cardium's Chief Scientific Officer, Gabor M. Rubanyi, M.D., Ph.D. A copy of the press release is attached as Exhibit 99.1 and incorporated by reference herein.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

99.1 Press Release of Cardium issued on January 29, 2013

Add CXM to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for CXM - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.